Biologic Patents Expiring in 2044
✉ Email this page to a colleague
Biologic Patents With Estimated Expirations in 2044
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | October 25, 2005 | ⤷ Start Trial | 2044-03-08 |
| Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | October 25, 2005 | ⤷ Start Trial | 2044-07-19 |
| Omrix Biopharmaceuticals Ltd | EVITHROM | thrombin, topical (human) | Solution | 125247 | August 27, 2007 | ⤷ Start Trial | 2044-01-22 |
| Omrix Biopharmaceuticals Ltd | EVITHROM | thrombin, topical (human) | For Injection | 125247 | September 17, 2009 | ⤷ Start Trial | 2044-01-22 |
| Horizon Therapeutics Ireland Dac | KRYSTEXXA | pegloticase | Injection | 125293 | September 14, 2010 | ⤷ Start Trial | 2044-04-09 |
| Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | November 18, 2011 | ⤷ Start Trial | 2044-10-23 |
| Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | August 16, 2018 | ⤷ Start Trial | 2044-10-23 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
